Immunotherapy plus carbon ion radiation for stable solid tumors
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial studies whether adding carbon ion radiation to ongoing immunotherapy can help people whose cancer is currently stable. It targets solid cancers where scans show the disease is not growing quickly, aiming to improve control without causing unsafe side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to sign a consent form and follow the study schedule for visits and tests.
- Your cancer must be a solid tumor confirmed by biopsy and be on single-drug anti–PD-1/PD-L1 immunotherapy as per Italian approval rules.
- Your cancer must be considered “stable” based on the study’s monitoring form and scan rules.
- CT or MRI scans must show at least 2 measurable spots; at least one spot will be tracked by standard response rules and one spot must be suitable for carbon ion radiation.
- Your health and daily functioning must be limited to an ECOG score of 0 to 2 (generally able to do self-care).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining an immune system medicine (PD-1/PD-L1 inhibitor) with radiation can improve outcomes in people with certain solid cancers. It also looks for blood or tissue “biomarkers” that may explain who benefits most.
This trial tests a combination of an immunotherapy drug (sintilimab) plus chemotherapy to shrink inoperable stage IIIC lung cancer. The goal is to make the cancer small enough to remove with surgery and improve survival.
This study tests whether combining immunotherapy (which boosts your immune system) with a precise, high-dose radiation treatment called SBRT can help people with advanced cancer live longer. It is for patients with at least 6 tumors that have spread, and aims to see if this treatment shrinks tumors and is safe.
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial tests a combination of chemotherapy, immunotherapy, and carbon ion radiation for people with non-small cell lung cancer that cannot be removed by surgery and has not spread to other parts of the body. It aims to see if this approach is safe and effective.
This trial tests a new treatment that combines immunotherapy (drugs that help your immune system fight cancer) with carbon ion radiation (a precise type of radiation) for people with locally advanced cervical cancer that hasn't spread to other organs. The goal is to see if this combination is safe and effective.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.